What can ATP content tell us about Barth syndrome muscle phenotypes? [PDF]
Brault JJ, Conway SJ.
europepmc +1 more source
Tafazzin-deficient zebrafish display mitochondrial dysfunction, neutropenia, and metabolic defects without myopathy. [PDF]
Oyarbide U +10 more
europepmc +1 more source
Emerging roles of pyruvate dehydrogenase phosphatase 1: a key player in metabolic health. [PDF]
Kumar V, Greenberg ML.
europepmc +1 more source
Cranial, Renal, and Skeletal Anomalies in a Fetus With a Pathogenic Variant in the TAFAZZIN Gene. [PDF]
Muir CR, Gilmore KL, Singh S, Vora NL.
europepmc +1 more source
Contemporary insights into elamipretide's mitochondrial mechanism of action and therapeutic effects. [PDF]
Sabbah HN +8 more
europepmc +1 more source
Cell-Penetrating Peptide Enhances Tafazzin Gene Therapy in Mouse Model of Barth Syndrome. [PDF]
Raghav R +5 more
europepmc +1 more source
ECG Findings Are Poor Predictors for Adverse Events and Cardiac Death in Barth Syndrome. [PDF]
Hutchinson A +3 more
europepmc +1 more source
atrophy plus syndrome, or costeff optic atrophy syndrome): identification of the OPA3 gene and its found mutation in Iraqi Jews, ” Am J Hum Genet 2001; 69(6): 1218-1224. [PDF]
Arbelaez A +3 more
core
Mitochondrial cristae remodeling: Mechanisms, functions, and pathology. [PDF]
Yu J +7 more
europepmc +1 more source
Reduced protein kinase C delta in a high molecular weight complex in mitochondria and elevated creatine uptake into Barth syndrome B lymphoblasts. [PDF]
Mejia EM +3 more
europepmc +1 more source

